Logo image of SLI

STANDARD LITHIUM LTD (SLI) Stock Fundamental Analysis

USA - NYSEARCA:SLI - CA8536061010 - Common Stock

5.135 USD
-0.12 (-2.38%)
Last: 10/14/2025, 2:00:08 PM
Fundamental Rating

3

SLI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. While SLI has a great health rating, there are worries on its profitability. SLI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SLI had negative earnings in the past year.
In the past year SLI has reported a negative cash flow from operations.
In the past 5 years SLI reported 4 times negative net income.
In the past 5 years SLI always reported negative operating cash flow.
SLI Yearly Net Income VS EBIT VS OCF VS FCFSLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of SLI (-13.09%) is worse than 73.72% of its industry peers.
Looking at the Return On Equity, with a value of -14.78%, SLI is doing worse than 67.31% of the companies in the same industry.
Industry RankSector Rank
ROA -13.09%
ROE -14.78%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
SLI Yearly ROA, ROE, ROICSLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLI Yearly Profit, Operating, Gross MarginsSLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for SLI has been increased compared to 1 year ago.
The number of shares outstanding for SLI has been increased compared to 5 years ago.
SLI has a better debt/assets ratio than last year.
SLI Yearly Shares OutstandingSLI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLI Yearly Total Debt VS Total AssetsSLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SLI has an Altman-Z score of 19.25. This indicates that SLI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SLI (19.25) is better than 79.49% of its industry peers.
SLI has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.01, SLI belongs to the top of the industry, outperforming 97.44% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that SLI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, SLI belongs to the top of the industry, outperforming 83.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 19.25
ROIC/WACCN/A
WACCN/A
SLI Yearly LT Debt VS Equity VS FCFSLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SLI has a Current Ratio of 5.48. This indicates that SLI is financially healthy and has no problem in meeting its short term obligations.
SLI's Current ratio of 5.48 is amongst the best of the industry. SLI outperforms 82.69% of its industry peers.
SLI has a Quick Ratio of 5.48. This indicates that SLI is financially healthy and has no problem in meeting its short term obligations.
SLI has a Quick ratio of 5.48. This is amongst the best in the industry. SLI outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.48
Quick Ratio 5.48
SLI Yearly Current Assets VS Current LiabilitesSLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SLI have decreased strongly by -23.75% in the last year.
EPS 1Y (TTM)-23.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

SLI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.32% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y83.17%
EPS Next 2Y31.08%
EPS Next 3Y14.03%
EPS Next 5Y21.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLI Yearly Revenue VS EstimatesSLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 50M 100M 150M 200M 250M
SLI Yearly EPS VS EstimatesSLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLI Price Earnings VS Forward Price EarningsSLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SLI indicates a somewhat cheap valuation: SLI is cheaper than 74.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.14
EV/EBITDA N/A
SLI Per share dataSLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

SLI's earnings are expected to grow with 14.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.08%
EPS Next 3Y14.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STANDARD LITHIUM LTD

NYSEARCA:SLI (10/14/2025, 2:00:08 PM)

5.135

-0.12 (-2.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)03-26 2026-03-26/bmo
Inst Owners8.14%
Inst Owner Change0%
Ins Owners3.18%
Ins Owner Change0%
Market Cap995.88M
Analysts83.08
Price Target3.69 (-28.14%)
Short Float %4.84%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.41%
Min EPS beat(2)-29.53%
Max EPS beat(2)68.35%
EPS beat(4)2
Avg EPS beat(4)-86.27%
Min EPS beat(4)-394.26%
Max EPS beat(4)68.35%
EPS beat(8)2
Avg EPS beat(8)-179.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.08%
PT rev (3m)27.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.87%
EPS NY rev (1m)38.3%
EPS NY rev (3m)31.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 34.14
P/OCF N/A
P/B 4.08
P/tB 4.1
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)0.15
FCFY2.93%
OCF(TTM)0
OCFYN/A
SpS0
BVpS1.26
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.09%
ROE -14.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr 27635.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.48
Quick Ratio 5.48
Altman-Z 19.25
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3831.28%
Cap/Depr(5y)2403.59%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y83.17%
EPS Next 2Y31.08%
EPS Next 3Y14.03%
EPS Next 5Y21.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.32%
EBIT Next 3Y8.94%
EBIT Next 5Y40.98%
FCF growth 1Y139.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.85%
OCF growth 3YN/A
OCF growth 5YN/A